A convergence of powerful market forces will push life sciences employers to rethink their workforce strategies and reimagine how critical work gets done, writes Ruby van den Hoff.
The global vaccine clinical trials landscape presents unprecedented opportunities. This report analyses emerging trends, regional opportunities, and Australia’s distinctive strengths in vaccine development.
Explore how thoughtful, well-supported transportation strategies can reduce barriers, enhance participant retention, and strengthen the overall success of clinical trials.
Learn more about a major life sciences investment that is bringing 500 new jobs to North Carolina, strengthening U.S. drug manufacturing, and advancing treatments for oncology and neurological diseases.
Ocular endpoints often introduce unique bottlenecks that can stall enrollment and compromise data integrity. This presentation provides the tools for a streamlined, resilient clinical trial strategy.
See the implications of the newly enacted "One Big Beautiful Bill" and how it will alleviate the administrative burdens faced by clinical research stakeholders and benefit low-income patients.
Despite clinical trial awareness campaigns and site expansions, trials continue to fall short in reaching the patients who need them most, resulting in a shift toward community-rooted recruitment.
Discover key challenges in accessing and preparing analytics-ready clinical data, how FAIR guiding principles can help maximize the value of clinical trial data, and the impact of innovative analytics.
Unveil a comprehensive overview of the challenges, requirements, and best practices for safely working with highly potent compounds in drug development and manufacturing.
